Innate Immunity and SARS-CoV-2 Vaccine Response in Hemodialysis Patients.
Kidney360
; 3(10): 1763-1768, 2022 10 27.
Article
in English
| MEDLINE | ID: covidwho-2111636
ABSTRACT
Patients receiving hemodialysis (HD) have more inflammatory monocytes and less plasmacytoid dendritic cells (DCs) compared with healthy controls.Patients on HD who have a poor antibody response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine had fewer monocyte-derived DCs and conventional DCs compared with good responders.The defects in antigen presentation might be possible therapeutic targets to increase vaccine efficacy in HD patients.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Kidney360
Year:
2022
Document Type:
Article
Affiliation country:
KID.0002542022
Similar
MEDLINE
...
LILACS
LIS